First-pass elimination of a peptidomimetic thrombin inhibitor is due to carrier-mediated uptake by the liver - Introduction with bile acid transport systems

被引:19
作者
Eckhardt, U
Stuber, W
Dickneite, G
Reers, M
Petzinger, E
机构
[1] UNIV GIESSEN, DEPT PHARMACOL & TOXICOL, D-35392 GIESSEN, GERMANY
[2] BEHRINGWERKE AG, RES LABS, D-35501 MARBURG, GERMANY
关键词
blood coagulation; CRC; 220; bile elimination; membrane transport; bioavailability; hepatocyte;
D O I
10.1016/0006-2952(96)00141-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
CRC 220 (4-methoxy-2, 3, 6-trimethylphenylsulfonyl-L-aspartyl-D-4-amidinophenylalanyl- piperidide) is a competitive peptide-based trombin inhibitor with high affinity to human alpha-thrombin (K-i 2.5 nM). The amphiphilic compound exhibits virtually no systemic bioavailability despite proteolytic stability and proven enteral absorption. After intravenous application (V. jejunalis) in rats CRC 220 is almost completely excreted into bile. Simultaneous administration of bile acids considerably decreases this first-pass elimination. CRC 220 is extensively taken up in isolated rat hepatocytes by a saturable carrier-mediated transport with K-m 23.7 mu M and V-max 775 pmol x mg(-1) x min(-1). A large part of this transport is energy dependent. At temperatures above 20 degrees C, the uptake is accelerated exponentially. The activation energy amounts to 82 kJ/mol. A minor portion of CRC 220 uptake occurs by physical diffusion with a permeability coefficient of 7.83 x 10(-7) cm/sec at 12 degrees C. Sodium ions energize CRC 220 uptake. Replacement of sodium by choline or lithium decreases the transport rate of 23-40%. In addition, a negative membrane potential facilitates the uptake. CRC 220 transport is only observed in hepatocytes: it is absent in BHK, FAO, HepG2, HPCT 1E3, and HPCT 1E3-TC cells. In the presence of 4-amidinophenylalanine derivatives, CRC 220 uptake is considerably decreased. Inhibition also occurs with bile acids and bromosulfophthalein, but less with bumetanide. Because CRC 220 inhibits bile acid uptake into hepatocytes and vice versa, the results suggest that the first pass elimination of this amphiphilic thrombin inhibitor is due to an active carrier-mediated transport process in the basolateral plasma membrane of rat hepatocytes, and that this transport occurs via a bile acid transport system.
引用
收藏
页码:85 / 96
页数:12
相关论文
共 51 条
[1]   CONTROLLED SYNTHESIS OF HBSAG IN A DIFFERENTIATED HUMAN-LIVER CARCINOMA-DERIVED CELL-LINE [J].
ADEN, DP ;
FOGEL, A ;
PLOTKIN, S ;
DAMJANOV, I ;
KNOWLES, BB .
NATURE, 1979, 282 (5739) :615-616
[2]  
ARONSON JK, 1990, Q J MED, V74, P111
[3]  
BAGDY D, 1992, THROMB HAEMOSTASIS, V68, P125
[4]   ACTIVE SITE-DIRECTED SYNTHETIC THROMBIN INHIBITORS - SYNTHESIS, INVITRO AND INVIVO ACTIVITY PROFILE OF BMY 44621 AND ANALOGS - AN EXAMINATION OF THE ROLE OF THE AMINO GROUP IN THE D-PHE-PRO-ARG-H SERIES [J].
BALASUBRAMANIAN, N ;
STLAURENT, DR ;
FEDERICI, ME ;
MEANWELL, NA ;
WRIGHT, JJ ;
SCHUMACHER, WA ;
SEILER, SM .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (02) :300-303
[5]   HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS - A BIOCHEMICAL AND FINE STRUCTURAL STUDY [J].
BERRY, MN ;
FRIEND, DS .
JOURNAL OF CELL BIOLOGY, 1969, 43 (03) :506-+
[6]   HEPATOCELLULAR UPTAKE OF PEPTIDES BY BILE-ACID TRANSPORTERS - RELATIONSHIP OF CARRIER-MEDIATED TRANSPORT OF LINEAR PEPTIDES WITH RENIN-INHIBITING ACTIVITY TO MULTISPECIFIC BILE-ACID CARRIERS [J].
BERTRAMS, A ;
ZIEGLER, K .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1091 (03) :337-348
[7]  
BLUMRICH M, 1994, EUR J CELL BIOL, V64, P339
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]  
DESCHATRETTE J, 1974, BIOCHIMIE, V56, P1603
[10]   ISOLATION AND SUBFRACTIONATION ON FICOLL GRADIENTS OF ADULT RAT HEPATOCYTES - SIZE, MORPHOLOGY, AND BIOCHEMICAL CHARACTERISTICS OF CELL FRACTIONS [J].
DROCHMANS, P ;
WANSON, JC ;
MOSSELMANS, R .
JOURNAL OF CELL BIOLOGY, 1975, 66 (01) :1-22